Skip to search formSkip to main contentSkip to account menu

3,4,5-trihydroxybenzamidoxime

Known as: trimidox 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Resistance to cytotoxic nucleoside analogues is a major problem in cancer treatment. The cellular mechanisms involved in this… 
Highly Cited
2003
Highly Cited
2003
Objective: To determine the role of oxidative stress in mediating HIV dementia and to identify novel therapeutic compounds that… 
2000
2000
Upon appropriate drug treatment, the human erythroleukemic K562 cells have been shown to produce hemoglobin and F‐cells. Fetal… 
1999
1999
Inhibitors of the cellular enzyme ribonucleotide reductase (hydroxyurea, [HU]) have been proposed as a new therapeutic strategy… 
1997
1997
The DNA-protective activity of hydroxyurea (HU) and novel ribonucleotide reductase (RR) inhibitors amidox (AX), didox (DX) and… 
1995
1995
Ribonucleotide reductase is the rate limiting enzyme of deoxynucleoside triphosphate synthesis and is considered to be an… 
1994
1994
Increased ribonucleotide reductase (RR) activity has been linked with malignant transformation and tumor cell growth. Therefore…